Advertisement
Screener

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) Graph

PRTA Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $1.01M; Research and development $8.80M; Operating expenses $22.11M; Income tax $2.00K.
  • 2026-03-31: Revenue $51.08M; Research and development $12.63M; Operating expenses $21.05M; Income tax $1.00K.
  • 2025-12-31: Revenue $21.00K*; Research and development $14.59M*; Operating expenses $24.22M*; Income tax $10.00K*.
  • 2025-09-30: Revenue $2.42M; Research and development $28.94M; Operating expenses $42.66M; Income tax -$371.00K.

Counterparty Name

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PRTA revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Bristol Myers Squibb-$1.00MRevenue$1.01MOperating expenses$22.11MOperating income-$21.10MOther income, net-$33.00KResearch & development$8.80MPre-tax income-$18.58MIncome tax$2.00KNet income-$18.58M

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PRTA revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.License$0.00Collaboration$1.01MRevenue$1.01MOperating expenses$22.11MOperating income-$21.10MOther income, net-$33.00KResearch & development$8.80MPre-tax income-$18.58MIncome tax$2.00KNet income-$18.58M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$1.01M$8.80M$22.11M$2.00K-$18.58M
2026-03-31$51.08M$12.63M$21.05M$1.00K$32.72M
2025-12-31$21.00K*$14.59M*$24.22M*$10.00K*-$21.59M*
2025-09-30$2.42M$28.94M$42.66M-$371.00K-$36.54M
2025-06-30$4.42M$40.52M$89.04M$44.80M-$125.77M
2025-03-31$2.83M$50.81M$68.41M-$1.18M-$60.20M
2024-09-30$970.00K$50.72M$67.48M-$835.00K-$59.00M
2024-06-30$132.01M$57.51M$73.64M-$2.04M$66.89M
2024-03-31$50.00K$64.11M$81.58M-$2.20M-$72.24M
2023-09-30$84.87M$57.91M$74.56M-$3.09M$21.91M
2023-06-30$4.02M$56.01M$70.52M-$4.31M-$54.59M
2023-03-31$2.17M$44.76M$58.49M-$2.91M-$46.86M
2022-09-30$1.52M$39.86M$51.85M-$2.65M-$45.76M
2022-06-30$1.31M$31.57M$44.52M-$1.33M-$41.24M
2022-03-31$1.15M$27.26M$39.10M-$1.67M-$36.29M
2021-09-30$139.17M$17.99M$29.95M-$51.00K$109.25M
2021-06-30$60.07M$21.09M$32.12M$254.00K$27.64M
2021-03-31$160.00K$21.14M$32.27M$4.66M-$36.73M
2020-12-31$360.00K(m)$30.67M(m)-$30.72M
2020-09-30$157.00K$21.61M$31.00M-$215.00K-$30.58M
2020-06-30$195.00K$17.27M$26.93M-$255.00K-$26.28M
2020-03-31$141.00K$15.25M$24.99M-$166.00K-$23.57M
2019-12-31$256.00K(m)$23.53M(m)-$21.55M
2019-09-30$205.00K$12.49M$21.18M$468.00K-$19.45M
2019-06-30$167.00K$9.58M$18.66M-$156.00K-$15.81M
2019-03-31$186.00K$13.30M$23.14M$198.00K-$20.86M
2018-12-31$194.00K(m)$22.95M(m)-$22.46M
2018-09-30$255.00K$18.52M$24.58M$962.00K-$24.56M
2018-06-30$279.00K$31.45M$63.35M-$1.95M-$59.88M
2018-03-31$227.00K$34.71M$48.94M-$37.00K-$48.74M
2017-12-31$229.00K(m)$47.55M(m)-$47.76M
2017-09-30$219.00K$41.31M$53.75M-$1.71M-$52.39M
2017-06-30$26.81M$34.03M$44.94M-$1.29M-$17.70M
2017-03-31$259.00K$25.70M$36.53M-$1.66M-$35.38M
2016-12-31$171.00K(m)$49.45M(m)-$48.90M
2016-09-30$286.00K$26.84M$42.97M$421.00K-$43.24M
2016-06-30$333.00K$32.36M$40.49M$189.00K-$40.45M
2016-03-31$265.00K$20.49M$27.68M$181.00K-$27.52M
2015-12-31$307.00K(m)$24.52M(m)-$24.16M
2015-09-30$429.00K$17.18M$23.09M$238.00K-$22.98M
2015-06-30$278.00K$12.79M$18.31M$195.00K-$18.28M
2015-03-31$593.00K$10.57M$15.62M$266.00K-$15.20M
2014-12-31$2.01M(m)$15.12M(m)-$13.11M
2014-09-30$1.49M$10.39M$14.62M$241.00K-$13.18M
2014-06-30$15.12M$8.62M$13.55M$296.00K$1.29M
2014-03-31$32.23M$9.34M$14.21M$151.00K$17.85M
2013-12-31$167.00K(m)$10.87M(m)-$11.05M
2013-09-30$171.00K$6.35M$9.74M$137.00K-$9.69M
2013-06-30$167.00K$8.15M$11.36M$124.00K-$11.30M
2013-03-31$171.00K$5.96M$9.14M$6.00K-$8.95M
2012-12-31(m)(m)$12.79M(m)-$12.22M
2012-09-30(m)$7.53M$9.61M$0.00-$8.67M
2012-06-30(m)$8.02M$10.45M(m)-$9.71M
2012-03-31(m)$8.76M$11.21M(m)-$10.81M

Revenue and expense 6 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$52.09M$21.43M$43.16M$3.00K$14.14M
2025-06-30$7.25M$91.33M$157.44M$43.62M-$185.96M
2024-06-30$132.06M$121.62M$155.22M-$4.24M-$5.35M
2023-06-30$6.19M$100.77M$129.02M-$7.22M-$101.46M
2022-06-30$2.46M$58.83M$83.62M-$3.00M-$77.53M
2021-06-30$60.23M$42.23M$64.39M$4.91M-$9.09M
2020-06-30$336.00K$32.52M$51.92M-$421.00K-$49.85M
2019-06-30$353.00K$22.88M$41.80M$42.00K-$36.67M
2018-06-30$506.00K$66.16M$112.28M-$1.98M-$108.63M
2017-06-30$27.07M$59.73M$81.47M-$2.95M-$53.09M
2016-06-30$598.00K$52.85M$68.17M$370.00K-$67.97M
2015-06-30$871.00K$23.36M$33.94M$461.00K-$33.48M
2014-06-30$47.35M$17.96M$27.77M$447.00K$19.14M
2013-06-30$338.00K$14.10M$20.50M$130.00K-$20.25M
2012-06-30(m)$16.78M$21.66M(m)-$20.52M

Revenue and expense 9 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$9.66M$120.27M$200.10M$43.25M-$222.50M
2024-09-30$133.03M$172.35M$222.70M-$5.08M-$64.35M
2023-09-30$91.05M$158.68M$203.57M-$10.31M-$79.55M
2022-09-30$3.98M$98.69M$135.47M-$5.65M-$123.30M
2021-09-30$199.41M$60.23M$94.34M$4.86M$100.15M
2020-09-30$493.00K$54.12M$82.92M-$636.00K-$80.43M
2019-09-30$558.00K$35.37M$62.98M$510.00K-$56.12M
2018-09-30$761.00K$84.67M$136.86M-$1.02M-$133.18M
2017-09-30$27.29M$101.05M$135.23M-$4.65M-$105.48M
2016-09-30$884.00K$79.69M$111.14M$791.00K-$111.20M
2015-09-30$1.30M$40.55M$57.02M$699.00K-$56.45M
2014-09-30$48.84M$28.34M$42.38M$688.00K$5.96M
2013-09-30$509.00K$20.45M$30.23M$267.00K-$29.94M
2012-09-30(m)$24.31M$31.27M$0.00-$29.19M

Revenue and expense 12 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$9.68M$134.85M$224.32M$43.26M-$244.09M
2024-12-31$135.16M$222.52M$289.72M-$6.62M-$122.31M
2023-12-31$91.37M$220.57M$282.41M-$13.45M-$147.03M
2022-12-31$53.91M$135.56M$185.46M-$8.66M-$116.95M
2021-12-31$200.58M$82.28M$128.60M$4.95M$66.97M
2020-12-31$853.00K$74.88M$113.59M-$283.00K-$111.14M
2019-12-31$814.00K$50.84M$86.51M$379.00K-$77.68M
2018-12-31$955.00K$101.18M$159.81M-$470.00K-$155.65M
2017-12-31$27.52M$134.55M$182.77M-$4.37M-$153.24M
2016-12-31$1.05M$119.53M$160.59M$1.14M-$160.11M
2015-12-31$1.61M$58.44M$81.54M$701.00K-$80.61M
2014-12-31$50.85M$38.45M$57.50M$811.00K-$7.15M
2013-12-31$676.00K$26.05M$41.10M$415.00K-$41.00M
2012-12-31$2.66M$34.14M$44.07M$6.00K-$41.41M
2011-12-31(m)$24.17M$29.75M$426.00K-$29.67M

Similar stocks

Stock NameCountryMarket CapPE Ratio
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10